Emergence Capital
18
42M
13
0.22
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 0
- Follow on index
- 0.22
- Investments by industry
- FinTech (8)
- SaaS (6)
- Bitcoin (5)
- Financial Exchanges (5)
- Blockchain (5) Show 31 more
- Investments by region
- United States (13)
- South Korea (1)
- India (1)
- Canada (2)
- Peak activity year
- 2021
- Number of Unicorns
- 4
- Number of Decacorns
- 4
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 0.89
- Strategy success index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Bitmama | 07 Jul 2021 | Financial Services, FinTech, Bitcoin, Cryptocurrency, Blockchain, Financial Exchanges, Ethereum | Seed | 150K | United States, Delaware, Claymont |
| Saleo | 05 Oct 2023 | Software, Sales, SaaS | Early Stage Venture | 13M | United States, Atlanta, Georgia |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Phantom Neuro | Apr 15, 2025 | AI, Enabling Software, Neurotechnology, Prosthetic Limbs, Robotic Exoskeletons, Robotic Orthopedic Technologies | - | 19000000 USD | |
| EnPlusOne Biosciences | Feb 19, 2025 | Biotechnology, Enzymatic Synthesis, RNA Synthesis, RNA Therapeutics, Sustainable Manufacturing, Therapeutic Modifications | - | 10000000 USD | |
| Copernic Catalysts | Nov 13, 2024 | Computational Design, E-fuels, High-throughput Experimentation, Sustainable Chemicals | Early stage | 8000000 USD | |
| Passkey Therapeutics | Oct 22, 2024 | Computational and Experimental Platform, Synergistic Multifunctional Therapeutics, Therapeutic Areas | Early stage | 20000000 USD | |
| ZymoChem | Jan 16, 2024 | Bio-based materials, Bio-based Materials, Bio-manufacturing, Sustainability | Early stage | 21000000 USD |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.